Yesterday, the second China Gene Industry Cluster Conference was held in 2008. Over 300 world-leading scientists and business representatives from around the world gathered in the small town of Sanshui. On the same day, it signed four projects, the China South China Medical Device Corporation Incubation Center, the National Food and Drug Administration Guangzhou Medical Device Supervision and Inspection Center Three Water Center Project, the South China Gene Valley, and the Nobel Research Center.
In addition, in response to international controversy over the harmful effects of genetically modified foods, Dr. Avraham Hershko, the Nobel Prize winner in chemistry in 2004, responded yesterday that it is stupid not to allow the sale of genetically modified foods. Genetically modified foods are very resistant to fungi, are safe, and should be applied and promoted.
AIDS vaccine and cervical cancer vaccine are all in development
The 2nd China Gene Industry Cluster Conference was held in Sanshui on the 7th. It covered policies and regulations concerning the public health and safety measures of vaccines, the latest breakthroughs in vaccine research for all major human diseases, the development of new infectious diseases and vaccines, and the development of cutting-edge technologies, and animals. There are more than 30 thematic discussions on the development of aquatic vaccines and international project cooperation.
The reporter learned from the conference that at present, out of 37 statutory infectious diseases, 22 diseases are available for vaccine prevention and vaccines with at least 3 diseases are under development. In addition, a large number of new vaccines such as the AIDS vaccine, cervical cancer vaccine, and Helicobacter pylori vaccine are under development.
According to relevant sources, with the development of society and the improvement of the social and economic level, people are paying more and more attention to health. The immunization plan is a disease prevention work with the least input and the most benefit. It is an important measure to implement the national “prevention oriented†policy and protect vulnerable populations. It is hoped that this conference will promote the integration of the Chinese vaccine industry with international standards and accelerate the upgrading of vaccine products and biotechnology in China.
South China Gene Valley settled in Foshan Sanshui yesterday
At 6 o'clock last night, the first national medical device industry base in South China successfully signed a contract with South China Gene Valley. On the same day, there were four projects of China Medical Device South China Incubation Center, the State Food and Drug Administration Guangzhou Medical Device Supervision and Inspection Center Sanmo Center, and the Nobel Research Center.